Digoxigenin
Star0
Identification
- Generic Name
- Digoxigenin
- DrugBank Accession Number
- DB03671
- Background
Digoxigenin is a cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 390.5131
Monoisotopic: 390.240624198 - Chemical Formula
- C23H34O5
- Synonyms
- Lanadigenin
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as cardenolides and derivatives. These are steroid lactones containing a furan-2-one moiety linked to the C17 atom of a cyclopenta[a]phenanthrene derivative.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Steroids and steroid derivatives
- Sub Class
- Steroid lactones
- Direct Parent
- Cardenolides and derivatives
- Alternative Parents
- 3-beta-hydroxysteroids / 14-hydroxysteroids / 12-hydroxysteroids / Butenolides / Tertiary alcohols / Enoate esters / Secondary alcohols / Lactones / Cyclic alcohols and derivatives / Polyols show 5 more
- Substituents
- 12-hydroxysteroid / 14-hydroxysteroid / 2-furanone / 3-beta-hydroxysteroid / 3-hydroxysteroid / Alcohol / Aliphatic heteropolycyclic compound / Alpha,beta-unsaturated carboxylic ester / Carbonyl group / Carboxylic acid derivative show 17 more
- Molecular Framework
- Aliphatic heteropolycyclic compounds
- External Descriptors
- 3beta-hydroxy steroid, 3beta-sterol, 14beta-hydroxy steroid, 12beta-hydroxy steroid (CHEBI:42098) / Cardanolides and derivatives (LMST01120008)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- NQ1SX9LNAU
- CAS number
- 1672-46-4
- InChI Key
- SHIBSTMRCDJXLN-KCZCNTNESA-N
- InChI
- InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1
- IUPAC Name
- 4-[(1R,3aS,3bR,5aR,7S,9aS,9bS,11R,11aS)-3a,7,11-trihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one
- SMILES
- [H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])C[C@@H](O)[C@]12C)C1=CC(=O)OC1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 15478
- PubChem Substance
- 46509019
- ChemSpider
- 14728
- BindingDB
- 225707
- ChEBI
- 42098
- ChEMBL
- CHEMBL1153
- ZINC
- ZINC000003982471
- PDBe Ligand
- DOG
- Wikipedia
- Digoxigenin
- PDB Entries
- 1lke / 3ra7 / 4j8t / 4j9a / 5bvb
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0632 mg/mL ALOGPS logP 1.6 ALOGPS logP 1.84 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 7.15 Chemaxon pKa (Strongest Basic) -1.4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 86.99 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 105.16 m3·mol-1 Chemaxon Polarizability 42.7 Å3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9947 Blood Brain Barrier + 0.6266 Caco-2 permeable - 0.5482 P-glycoprotein substrate Substrate 0.7936 P-glycoprotein inhibitor I Non-inhibitor 0.881 P-glycoprotein inhibitor II Non-inhibitor 0.8417 Renal organic cation transporter Non-inhibitor 0.8028 CYP450 2C9 substrate Non-substrate 0.8038 CYP450 2D6 substrate Non-substrate 0.9018 CYP450 3A4 substrate Substrate 0.7262 CYP450 1A2 substrate Non-inhibitor 0.9046 CYP450 2C9 inhibitor Non-inhibitor 0.9099 CYP450 2D6 inhibitor Non-inhibitor 0.9362 CYP450 2C19 inhibitor Non-inhibitor 0.9256 CYP450 3A4 inhibitor Non-inhibitor 0.831 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8702 Ames test Non AMES toxic 0.8592 Carcinogenicity Non-carcinogens 0.9629 Biodegradation Not ready biodegradable 0.8827 Rat acute toxicity 3.4699 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9704 hERG inhibition (predictor II) Inhibitor 0.5085
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 196.8065226 predictedDarkChem Lite v0.1.0 [M-H]- 204.4256226 predictedDarkChem Lite v0.1.0 [M-H]- 202.7424226 predictedDarkChem Lite v0.1.0 [M-H]- 181.55898 predictedDeepCCS 1.0 (2019) [M+H]+ 199.5620226 predictedDarkChem Lite v0.1.0 [M+H]+ 207.6326226 predictedDarkChem Lite v0.1.0 [M+H]+ 205.2486226 predictedDarkChem Lite v0.1.0 [M+H]+ 183.38385 predictedDeepCCS 1.0 (2019) [M+Na]+ 197.7579226 predictedDarkChem Lite v0.1.0 [M+Na]+ 204.5716226 predictedDarkChem Lite v0.1.0 [M+Na]+ 203.1797226 predictedDarkChem Lite v0.1.0 [M+Na]+ 189.2958 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52